journal article·2022-08Open access

Activation of cGAS‐STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b+Ly6Chi Proinflammatory Monocytes

Yang Du, Yien Luo, Zhiqiang Hu, Jiansen Lu, Xin Liu, Changsheng Xing, Jian Wu, Tianhao Duan, Junjun Chu, Helen Y. Wang, Xin‐zhuan Su, Xiao Yu, Rong‐Fu Wang

Advanced Science· Volume 9· Issue 22

Abstract

Abstract Cyclic GMP‐AMP synthase (cGAS) and stimulator of interferon genes (STING) play critical roles in the innate immunity against infectious diseases and are required to link pathogen DNA sensing to immune responses. However, the mechanisms by which cGAS‐STING‐induced cytokines suppress the adaptive immune response against malaria infections remain poorly understood. Here, cGAS‐STING signaling is identified to play a detrimental role in regulating anti‐malaria immunity. cGAS or STING deficiency in mice markedly prolongs mouse survival during lethal malaria Plasmodium yoelii nigeriensis N67C infections by reducing late interleukin (IL)‐6 production. Mechanistically, cGAS/STING recruits myeloid differentiation factor 88 (MyD88) and specifically induces the p38‐dependent signaling pathway for late IL‐6 production, which, in turn, expands CD11b+Ly6Chi proinflammatory monocytes to inhibit immunity. Moreover, the blockage or ablation of the cGAS‐STING‐MyD88‐p38‐IL‐6 signaling axis or the depletion of CD11b+Ly6Chi proinflammatory monocytes provides mice a significant survival benefit during N67C and other lethal malaria‐strain infections. Taken together, these findings identify a previously unrecognized detrimental role of cGAS‐STING‐MyD88‐p38 axis in infectious diseases through triggering the late IL‐6 production and proinflammatory monocyte expansion and provide insight into how targeting the DNA sensing pathway, dysregulated cytokines, and proinflammatory monocytes enhances immunity against infection.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: interferon and immune responses · Mosquito-borne diseases and control · Viral Infections and Vectors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medicine and Norris Comprehensive Cancer Center Keck School of Medicine University of Southern California Los Angeles CA 90033 USA

Center for Inflammation and Epigenetics Houston Methodist Research Institute Houston TX 77030 USA

Department of Neurology Xiangya Hospital Central South University Changsha Hunan 410008 China

Department of Immunology Guangdong Provincial Key Lab of Single Cell Technology and Application School of Basic Medical Sciences Southern Medical University Guangzhou Guangdong 510515 China

Department of Joint Surgery The Fifth Affiliated Hospital Southern Medical University Guangzhou Guangdong 510515 China

Malaria Functional Genomics Section Laboratory of Malaria and Vector Research National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda MD 20892 USA

Department of Pediatrics Children's Hospital Keck School of Medicine University of Southern California Los Angeles CA 90027 USA

Funding

National Natural Science Foundation of China · Division of Intramural Research, National Institute of Allergy and Infectious Diseases · National Institutes of Health

References (89)

Show source-provided references
1. 10.1038/nm.308310.1038/nm.3083 ↗
2. 10.1007/s40265-018-0911-910.1007/s40265-018-0911-9 ↗
3. 10.1016/j.chom.2018.06.00810.1016/j.chom.2018.06.008 ↗
4. 10.1038/s41541-017-0035-310.1038/s41541-017-0035-3 ↗
5. 10.1038/nri131110.1038/nri1311 ↗
6. 10.1038/ni.f.20510.1038/ni.f.205 ↗
7. 10.1038/s41577-019-0158-z10.1038/s41577-019-0158-z ↗
8. 10.1038/s41598-018-33599-110.1038/s41598-018-33599-1 ↗
9. 10.1073/pnas.131646711110.1073/pnas.1316467111 ↗
10. 10.1016/j.cell.2006.02.01510.1016/j.cell.2006.02.015 ↗
11. 10.1016/j.cell.2010.01.02210.1016/j.cell.2010.01.022 ↗
12. 10.1016/j.molcel.2014.03.04010.1016/j.molcel.2014.03.040 ↗
13. 10.1038/nri374210.1038/nri3742 ↗
14. Ablasser A. · Science · 2019 · 363
15. 10.3389/fimmu.2018.0300610.3389/fimmu.2018.03006 ↗
16. 10.1016/j.immuni.2016.10.00110.1016/j.immuni.2016.10.001 ↗
17. 10.1371/journal.ppat.100597510.1371/journal.ppat.1005975 ↗
18. 10.1038/s41467-018-07384-710.1038/s41467-018-07384-7 ↗
19. 10.1038/nm.342410.1038/nm.3424 ↗
20. 10.1111/j.1600-065X.2011.01049.x10.1111/j.1600-065X.2011.01049.x ↗
21. 10.1038/nri235810.1038/nri2358 ↗
22. 10.1016/j.chom.2016.01.00710.1016/j.chom.2016.01.007 ↗
23. 10.1172/JCI7069810.1172/JCI70698 ↗
24. 10.1084/jem.2004097610.1084/jem.20040976 ↗
25. 10.1038/s41467-019-11819-010.1038/s41467-019-11819-0 ↗
26. 10.1016/j.immuni.2011.05.01610.1016/j.immuni.2011.05.016 ↗
27. 10.1038/s41392-020-0198-710.1038/s41392-020-0198-7 ↗
28. 10.1038/s41580-020-0244-x10.1038/s41580-020-0244-x ↗
29. 10.1128/JVI.00037-1410.1128/JVI.00037-14 ↗
30. 10.4049/jimmunol.170069910.4049/jimmunol.1700699 ↗
31. 10.1016/j.celrep.2019.03.09810.1016/j.celrep.2019.03.098 ↗
32. 10.3389/fimmu.2022.81277410.3389/fimmu.2022.812774 ↗
33. 10.1172/JCI8000510.1172/JCI80005 ↗
34. 10.1016/j.chom.2015.02.00710.1016/j.chom.2015.02.007 ↗
35. 10.1038/ncomms1215010.1038/ncomms12150 ↗
36. 10.1158/2326-6066.CIR-16-029710.1158/2326-6066.CIR-16-0297 ↗
37. 10.3389/fcimb.2020.61012110.3389/fcimb.2020.610121 ↗
38. 10.4049/jimmunol.170104810.4049/jimmunol.1701048 ↗
39. 10.1016/j.pt.2020.07.00110.1016/j.pt.2020.07.001 ↗
40. 10.4049/jimmunol.178.10.641610.4049/jimmunol.178.10.6416 ↗
41. 10.1128/IAI.00810-1010.1128/IAI.00810-10 ↗
42. 10.1111/imm.1297110.1111/imm.12971 ↗
43. 10.1084/jem.2008287410.1084/jem.20082874 ↗
44. 10.1038/nature2543210.1038/nature25432 ↗
45. 10.1016/j.immuni.2017.02.01410.1016/j.immuni.2017.02.014 ↗
46. 10.1084/jem.2016167410.1084/jem.20161674 ↗
47. 10.3390/cells810122810.3390/cells8101228 ↗
48. 10.3389/fimmu.2021.69970210.3389/fimmu.2021.699702 ↗
49. 10.1128/JVI.00527-0710.1128/JVI.00527-07 ↗
50. 10.1038/s41586-020-2588-y10.1038/s41586-020-2588-y ↗
51. 10.1038/s41590-020-00840-x10.1038/s41590-020-00840-x ↗
52. 10.1016/j.chom.2016.01.00710.1016/j.chom.2016.01.007 ↗
53. 10.1172/JCI12636310.1172/JCI126363 ↗
54. 10.1038/ni.218010.1038/ni.2180 ↗
55. 10.4049/jimmunol.120243810.4049/jimmunol.1202438 ↗
56. 10.1016/j.micinf.2016.06.00310.1016/j.micinf.2016.06.003 ↗
57. 10.1093/infdis/jiw42810.1093/infdis/jiw428 ↗
58. 10.1371/journal.ppat.100250410.1371/journal.ppat.1002504 ↗
59. 10.1038/nrclinonc.2018.810.1038/nrclinonc.2018.8 ↗
60. 10.1002/eji.20104091110.1002/eji.201040911 ↗
61. 10.3389/fcimb.2016.0003710.3389/fcimb.2016.00037 ↗
62. 10.1038/nri250610.1038/nri2506 ↗
63. 10.4049/jimmunol.090266110.4049/jimmunol.0902661 ↗
64. 10.1128/JVI.01759-1210.1128/JVI.01759-12 ↗
65. 10.1158/0008-5472.CAN-09-258710.1158/0008-5472.CAN-09-2587 ↗
66. 10.4049/jimmunol.160186010.4049/jimmunol.1601860 ↗
67. 10.1182/blood-2009-04-21748910.1182/blood-2009-04-217489 ↗
68. 10.1038/ncomms1327710.1038/ncomms13277 ↗
69. Perlmann P. · Folia Biol. · 2000 · 46 · 21010.14712/fb2000046060210 ↗
70. 10.1016/S0165-2478(98)00120-510.1016/S0165-2478(98)00120-5 ↗
71. 10.3389/fcimb.2017.0032410.3389/fcimb.2017.00324 ↗
72. Oyegue‐Liabagui S. L. · Am. J. Clin. Exp. Immunol. · 2017 · 6 · 9
73. 10.1002/iid3.8910.1002/iid3.89 ↗
74. 10.1086/50472010.1086/504720 ↗
75. 10.1371/journal.ppat.100439310.1371/journal.ppat.1004393 ↗
76. 10.1172/jci.insight.9535210.1172/jci.insight.95352 ↗
77. 10.1182/blood-2009-07-23502810.1182/blood-2009-07-235028 ↗
78. 10.1183/09031936.03.0004810310.1183/09031936.03.00048103 ↗
79. 10.1128/JVI.02620-1310.1128/JVI.02620-13 ↗
80. 10.1371/journal.ppat.100664010.1371/journal.ppat.1006640 ↗
81. 10.4049/jimmunol.180092710.4049/jimmunol.1800927 ↗
82. 10.1189/jlb.3HI0517-198R10.1189/jlb.3HI0517-198R ↗
83. 10.1016/j.ijantimicag.2020.10595410.1016/j.ijantimicag.2020.105954 ↗
84. 10.1073/pnas.200561511710.1073/pnas.2005615117 ↗
85. 10.1038/s41422-020-0282-010.1038/s41422-020-0282-0 ↗
86. 10.1002/jmv.2580110.1002/jmv.25801 ↗
87. Bizzarri M. · Eur. Rev. Med. Pharmacol. Sci. · 2020 · 24 · 3426
88. 10.1038/s42003-021-02983-510.1038/s42003-021-02983-5 ↗
89. Trouplin V. · J. Visualized Exp. · 2013 · 81 · e50966